Davis Capital Management’s Gilead Sciences GILD Stock Holding History

Davis Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1K	Buy	80 +69	+627%	+$9.09K	0.01%	262
2026 Q1	$1.53K	Hold	11	–	–	﹤0.01%	306
2025 Q4	$1.35K	Buy	11 +3	+38%	+$365	﹤0.01%	313
2025 Q3	$888	Buy	+8	New	+$909	﹤0.01%	348
2024 Q3	–	Sell	-28	Closed	-$1.92K	–	341
2024 Q2	$1.92K	Hold	28	–	–	﹤0.01%	286
2024 Q1	$2.04K	Hold	28	–	–	﹤0.01%	268
2023 Q4	$2.27K	Buy	+28	New	+$2.18K	﹤0.01%	268
2020 Q2	$17K	Sell	225 -12	-5%	-$920	0.03%	167
2020 Q1	$18K	Buy	+237	New	+$16.4K	0.04%	163

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Davis Capital Management's GILD Position: Q2 2026 in Review

Davis Capital Management increased its Gilead Sciences (GILD) stake by 627% in Q2 2026, buying an estimated $9.09K and bringing the position to 80 shares worth $10.1K. The position accounts for 0.01% of the portfolio, ranked #262.

Davis Capital Management first reported a position in GILD in Q1 2020 and has held it in 9 quarters since. The position peaked at $18K in Q1 2020. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Davis Capital Management held 80 shares of Gilead Sciences worth $10.1K as of Q2 2026.
Davis Capital Management bought 69 Gilead Sciences shares in Q2 2026, an estimated $9.09K.
Gilead Sciences made up 0.01% of Davis Capital Management's portfolio in Q2 2026, its #262 holding.
Davis Capital Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 9 quarters since.
Davis Capital Management's Gilead Sciences position peaked at $18K in Q1 2020.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.